This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Crysvita
  • /
  • Study of the Safety, Pharmacodynamics (PD) and Eff...
Clinical trial

Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)

Read time: 3 mins
Last updated:1st May 2016
Identifier: NCT02750618
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest